Radiofrequency ablation versus total thyroidectomy in patients with papillary thyroid microcarcinoma located in the isthmus: a retrospective cohort study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer J Clinic. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. A Cancer J Clinic. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Buj R, Mallona I, Diez-Villanueva A, et al. Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications. Thyroid. 2018;28(5):601–612.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Franceschi S, Bray F, et al. L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375(7):614–617.
   PubMed Web of Science ®Google Scholar
• Colonna M, Uhry Z, Guizard AV, et al. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015;39(4):511–518.
   PubMed Web of Science ®Google Scholar
• Topstad D, Dickinson JA. Thyroid cancer incidence in Canada: a national cancer registry analysis. CMAJ Open. 2017;5(3):E612-E6.
   Google Scholar
• Vargas-Pinto S, Romero Arenas MA. Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review. J Surg Res. 2019;242:244–251.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li Y, Li J, et al. Total thyroidectomy versus lobectomy for papillary thyroid cancer: a systematic review and meta-analysis. Medicine. 2020;99(6):e19073.
   PubMed Web of Science ®Google Scholar
• Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(12):1856–1883.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR, et al.; American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Vasileiadis I, Boutzios G, Karalaki M, et al. Papillary thyroid carcinoma of the isthmus: total thyroidectomy or isthmusectomy? Am J Surg. 2018;216(1):135–139.
   PubMed Web of Science ®Google Scholar
• Nixon IJ, Palmer FL, Whitcher MM, et al. Thyroid isthmusectomy for well-differentiated thyroid cancer. Ann Surg Oncol. 2011;18(3):767–770.
   PubMed Web of Science ®Google Scholar
• Tufano RP, Clayman G, Heller KS, et al. Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. Thyroid. 2015;25(1):15–27.
   PubMed Web of Science ®Google Scholar
• Sakai T, Sugitani I, Ebina A, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29(1):59–63.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
   PubMed Web of Science ®Google Scholar
• Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144(4):771–779.
   PubMed Web of Science ®Google Scholar
• Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2018;34(5):611–616.
   PubMed Web of Science ®Google Scholar
• Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2014;30(2):150–157.
   PubMed Web of Science ®Google Scholar
• Hahn SY, Han BK, Ko EY, et al. Ultrasound findings of papillary thyroid carcinoma originating in the isthmus: comparison with lobe-originating papillary thyroid carcinoma. AJR Am J Roentgenol. 2014;203(3):637–642.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417.
   PubMed Web of Science ®Google Scholar
• Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010;194(4):1137–1142.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
   PubMed Web of Science ®Google Scholar
• Jeon YW, Gwak HG, Lim ST, et al. Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann Surg Oncol. 2019;26(9):2952–2958.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2017;33(2):212–219.
   PubMed Web of Science ®Google Scholar
• Husson O, Haak HR, Mols F, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncologica. 2013;52(2):447–454.
   PubMed Web of Science ®Google Scholar
• Mauri G, Gennaro N, Lee MK, et al. Laser and radiofrequency ablations for benign and malignant thyroid tumors. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2019;36(2):13–20.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline: korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655.
   PubMed Web of Science ®Google Scholar
• Mauri G, Nicosia L, Della VP, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.
   PubMed Web of Science ®Google Scholar
• Hahn SY, Shin JH, Na DG, et al. Ethanol ablation of the thyroid nodules: 2018 consensus statement by the Korean society of thyroid radiology. Korean J Radiol. 2019;20(4):609–620.
   PubMed Web of Science ®Google Scholar
• Karatzas T, Charitoudis G, Vasileiadis D, et al. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: a case control study. Inter J Surg. 2015;18:64–68.
   PubMed Web of Science ®Google Scholar
• Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Euro Radiol. 2008;18(6):1244–1250.
   PubMed Web of Science ®Google Scholar
• Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Euro Radiol. 2013;23(4):1044–1049.
   PubMed Web of Science ®Google Scholar
• Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19(1):167–174.
   PubMed Web of Science ®Google Scholar
• Cesareo R, Naciu AM, Iozzino M, et al. Nodule size as predictive factor of efficacy of radiofrequency ablation in treating autonomously functioning thyroid nodules. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2018;34(5):617–623.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Dobrinja C, Fabris B, et al. Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol. 2014;2014:934595.
   PubMed Web of Science ®Google Scholar
• Che Y, Jin S, Shi C, et al. Treatment of benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol. 2015;36(7):1321–1325.
   PubMed Web of Science ®Google Scholar
• Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of radiofrequency and ethanol ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis. Thyroid. 2016;26(3):420–428.
   PubMed Web of Science ®Google Scholar
• Kim JH, Yoo WS, Park YJ, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology. 2015;276(3):909–918.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL, Bae JS, Lee SH, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. North Am Hyperthermia Group. 2019;36(1):359–367.
   PubMed Web of Science ®Google Scholar
• Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer. Euro Radiol. 2019;29(9):4897–4903.
   PubMed Web of Science ®Google Scholar
• Lee YS, Jeong JJ, Nam KH, et al. Papillary carcinoma located in the thyroid isthmus. World J Surg. 2010;34(1):36–39.
   PubMed Web of Science ®Google Scholar
• Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.
   PubMed Web of Science ®Google Scholar
• Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26(1):150–155.
   PubMed Web of Science ®Google Scholar
• Lim ST, Jeon YW, Suh YJ. Correlation between surgical extent and prognosis in node-negative, early-stage papillary thyroid carcinoma originating in the Isthmus. World J Surg. 2016;40(2):344–349.
   PubMed Web of Science ®Google Scholar
• Doescher J, Veit JA, Hoffmann TK. [The 8th edition of the AJCC Cancer Staging Manual: Updates in otorhinolaryngology, head and neck surgery]. Hno. 2017;65(12):956–961.
   PubMed Web of Science ®Google Scholar
• Seok J, Choi JY, Yu HW, Jung YH, et al. Papillary thyroid cancers of the thyroid isthmus: the pattern of nodal metastasis and the significance of extrathyroidal extension. Ann Surg Oncol. 2020;27(6):1937–1944.
   PubMed Web of Science ®Google Scholar
• Mete O, Rotstein L, Asa SL. Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol. 2010;17(2):386–391.
   PubMed Web of Science ®Google Scholar
• Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer. 1975;36(3):1095–1099.
   PubMed Web of Science ®Google Scholar